Proceedings: debilitating eye diseases.
Debilitating eye diseases such as age-related macular degeneration and retinitis pigmentosa currently represent a large unmet medical need that could potentially be addressed by stem cell therapy. A number of novel stem cell-based cellular therapies are now under development to treat a variety of eye diseases. The approaches being taken by the California Institute for Regenerative Medicine, together with its grantees, are discussed.
California Institute for Regenerative Medicine, San Francisco, California, USA icaras@cirm.ca.gov.
Ingrid W
IW
Caras
California Institute for Regenerative Medicine, San Francisco, California, USA.
Neil
N
Littman
California Institute for Regenerative Medicine, San Francisco, California, USA.
Arie
A
Abo
D064987:Cell- and Tissue-Based Therapy / Q000379:methods*; D006801:Humans; D012174:Retinitis Pigmentosa / Q000628:therapy*; D033581:Stem Cell Transplantation